Preview

Genij Ortopedii

Advanced search

Metabolic bone abnormalities underlying nonunion in revision foot surgeries

https://doi.org/10.18019/1028-4427-2026-32-1-57-64

Abstract

Introduction Revision foot surgery has increased in recent decades with the increasing surgical procedures. Nonunion is common after arthrodesis and osteotomies. From an economic perspective, revision surgery can be associated with greater length of disability imposing an additional financial burden on healthcare facilities. Impaired bone metabolism is one of the key factors leading to the risk of nonunion and a revision surgery.

The aim of the study was to determine the impact of metabolism bone abnormalities on the incidence of nonunion in revision foot and ankle surgery.

Material and methods A prospective study with retrospective control was conducted to compare two groups of patients aged 45 to 70 years who required revision foot surgery. The retrospective control group (n = 36) consisted of patients who had no bone metabolism assessment prior to revision foot surgery. The prospective group (n = 42) consisted of patients who underwent bone metabolism assessment preoperatively and subsequent correction if needed. Revision surgery was produced in the hindfoot and midfoot due to failed arthrodesis of the corresponding joints. AP and lateral weight-bearing radiographs of the foot, the Salzmann view and a CT scan of the feet were produced preoperatively.

Results The mean period from the initial consultation to surgical treatment was longer in the prospective group than in controls: (16.0 ± 4.0) weeks and (8.0 ± 1.7) weeks, respectively. There were no significant differences in the mean period of consolidation/ankylosis measuring (10.0 ± 2.2) weeks in controls and (8.0 ± 1.5) weeks in the prospective group. A statistically significant difference was found in the frequency of non-unions between the two groups showing 14 % (n = 5) in controls and 2.4 % (n = 1) in the prospective group.

Discussion The findings demonstrated clinical effectiveness of a comprehensive approach to revision foot surgery including optimization of biological factors for bone union. Protocol for preoperative assessment and correction of bone metabolism can significantly improve outcomes of revision procedures reducing the risk of recurrent nonunions and the need for revisions.

Conclusion The time from initial consultation to revision surgery was longer in the prospective group of patients with no statistically significant differences in the time to bone consolidation. The nonunion rate was higher in the control group with no diagnosis and correction of bone metabolism diagnostics performed, highlighting the importance in reducing the rate of revision foot and ankle surgeries.

About the Authors

A. K. Mursalov
Priorov National Medical Research Center of Traumatology and Orthopedics
Russian Federation

Anatoly K. Mursalov — Candidate of Medical Sciences, associate professor at the Department.

Moscow



A. M. Dzyuba
Priorov National Medical Research Center of Traumatology and Orthopedics
Russian Federation

Alexey M. Dzyuba — orthopaedic surgeon.

Moscow



A. S. Shipilov
Priorov National Medical Research Center of Traumatology and Orthopedics
Russian Federation

Alexander S. Shipilov — resident.

Moscow



M. S. Rogova
Priorov National Medical Research Center of Traumatology and Orthopedics
Russian Federation

Mariya S. Rogova — orthopaedic surgeon.

Moscow



E. A. Fedotov
Priorov National Medical Research Center of Traumatology and Orthopedics
Russian Federation

Eugene A. Fedotov — resident.

Moscow



References

1. Thevendran G, Wang C, Pinney SJ, et al. Nonunion Risk Assessment in Foot and Ankle Surgery: Proposing a Predictive Risk Assessment Model. Foot Ankle Int. 2015;36(8):901-907. doi: 10.1177/1071100715577789.

2. Greene H, Dodd A, Le I, LaMothe J. Nonunion in foot and ankle arthrodesis surgery: review of risk factors, identification of high-risk patients, and a guide to perioperative testing and optimization. J Am Acad Orthop Surg. 2024. doi: 10.5435/JAAOS-D-24-00500.

3. Perkins JM, Vacketta VG, Prissel MA. Triple Arthrodesis: How to Manage Failures, Malunion, and Nonunion. Clin Podiatr Med Surg. 2023;40(4):649-668. doi: 10.1016/j.cpm.2023.05.008.

4. Brinker MR, O'Connor DP, Monla YT, Earthman TP. Metabolic and endocrine abnormalities in patients with nonunions. J Orthop Trauma. 2007;21(8):557-70. doi: 10.1097/BOT.0b013e31814d4dc6.

5. Moore KR, Howell MA, Saltrick KR, Catanzariti AR. Risk Factors Associated With Nonunion After Elective Foot and Ankle Reconstruction: A Case-Control Study. J Foot Ankle Surg. 2017;56(3):457-462. doi: 10.1053/j.jfas.2017.01.011.

6. Salari N, Darvishi N, Bartina Y, et al, Mohammadi M. Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16(1):669. doi: 10.1186/s13018-021-02821-8.

7. Kakagia DD, Karadimas EJ, Stouras IA, Papanas N. The Ageing Foot. Int J Low Extrem Wounds. 2023:15347346231203279. doi: 10.1177/15347346231203279.

8. Kanis JA, McCloskey EV, Johansson H, Strom O, et al. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19(10):1395-1408. doi: 10.1007/s00198-008-0712-1.

9. Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-2381. doi: 10.1007/s00198-014-2794-2.

10. Frost HM. Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol. 2003;275(2):1081-1101. doi: 10.1002/ar.a.10119.

11. Romano F, Serpico D, Cantelli M, et al. Osteoporosis and dermatoporosis: a review on the role of vitamin D. Front Endocrinol (Lausanne). 2023;14:1231580. doi: 10.3389/fendo.2023.1231580.

12. Rentzeperi E, Pegiou S, Tsakiridis I, et al. Diagnosis and Management of Osteoporosis: A Comprehensive Review of Guidelines. Obstet Gynecol Surv. 2023;78(11):657-681. doi: 10.1097/OGX.0000000000001181.

13. Nuti R, Brandi ML, Checchia G, et al. Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med. 2019;14(1):85-102. doi: 10.1007/s11739-018-1874-2.

14. Chrea B, Day J, Henry J, et al. Influence of complications and revision surgery on fulfillment of expectations in foot and ankle surgery. Foot Ankle Int. 2021;42(7):859-866. doi: 10.1177/1071100720985231.

15. Greer N, Yoon P, Majeski B, Wilt TJ. Orthobiologics in foot and ankle arthrodesis sites: a systematic review [Internet]. Washington (DC): Department of Veterans Affairs (US); 2020.

16. Chraim M, Recheis S, Alrabai H, et al. Midterm outcome of subtalar joint revision arthrodesis. Foot Ankle Int. 2021;42(7):824-832. doi: 10.1177/1071100721995187.

17. Rao NM, Ligas C. The Ankle Joint: Revision Ankle Fusion Options, Nonunion, Malunion, Protocol for Best Outcome. Clin Podiatr Med Surg. 2023;40(4):703-710. doi: 10.1016/j.cpm.2023.05.011.

18. Cardoso DV, Veljkovic A. General Considerations About Foot and Ankle Arthrodesis. Any Way to Improve Our Results? Foot Ankle Clin. 2022;27(4):701-722. doi: 10.1016/j.fcl.2022.08.007.

19. Anciano V, Tran SK, Carr JB, et al. Incidence of vitamin D deficiency in foot and ankle arthrodesis nonunions. Cureus. 2024;16(3):e57028. doi: 10.7759/cureus.57028.

20. van Ballegooijen AJ, Pilz S, Tomaschitz A, et al. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review. Int J Endocrinol. 2017;2017:7454376. doi: 10.1155/2017/7454376.

21. Barvencik F. Medication and bone metabolism: Clinical importance for fracture treatment. Unfallchirurg. 2015;118(12):1017-1024. (In German). doi: 10.1007/s00113-015-0109-5.


Review

For citations:


Mursalov A.K., Dzyuba A.M., Shipilov A.S., Rogova M.S., Fedotov E.A. Metabolic bone abnormalities underlying nonunion in revision foot surgeries. Genij Ortopedii. 2026;32(1):57-64. https://doi.org/10.18019/1028-4427-2026-32-1-57-64

Views: 277

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1028-4427 (Print)
ISSN 2542-131X (Online)